The role of Ser-(Arg-Ser-Arg-Ser-GlucNAc)19-GlucNAc Fasciola gigantica glycoprotein in the diagnosis of prepatent fasciolosis in rabbits

详细信息    查看全文

• 作者：Eman H. Abdel-Rahman ; Azza H. Mohamed…
• 关键词：Fasciola gigantica ; GlucNAc ; Affinity column chromatography ; Diagnosis ; ELISA
• 刊名：Journal of Parasitic Diseases
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：40
• 期：1
• 页码：11-21
• 全文大小：1,688 KB
• 参考文献：Abdul-Salam F, Mansour MH (2000) Identification and localization of a schistosome-associated fucosyllactose determinant expressed by Fasciola hepatica. Comp Immunol Microbiol Infect Dis 2:99–111CrossRef
  Almazan C, Avila G, Quiroz H, Ibarra F, Ochoa P (2001) Effect of parasite burden on detection of Fasciola hepatica antigens in sera and feces of experimentally infected sheep. Vet Parasitol 97:101–112CrossRef PubMed
  Bachmann MF, Dyer MR (2004) Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nat Rev Drug Disco 3:81–88CrossRef
  Carbon FR, Gleeson PA (1997) Carbohydrates and antigen recognition by T cells. Glycobiology 7:725–730CrossRef
  Chalkley RJ, Thalhammer A, Schoepfer R, Burlingame AL (2009) Identification of protein O-Glc NAcylation sites using electron transfer dissociation mass spectrometry on native peptides. Proc Natl Acad Sci USA 106:8894–8899CrossRef PubMed PubMedCentral
  Chapaman CB, Mitchell GF (1982) Proteolytic cleavage of immunoglobulin by enzymes released by Fasciola hepatica. Vet Parasitol 11:165–178CrossRef
  Charlier J, De Meulemeester L, Claerebout E, Williams D, Vercruysse J (2008) Qualitative and quantitative evaluation of coprological and serological techniques for the diagnosis of fasciolosis in cattle. Vet Parasitol 153:44–51CrossRef PubMed
  Classon BA, Schneerson R, Lagergrd T, Trollfors B, Taranger J, Johansson J, Bryla D, Robbins JB (1991) Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age. Pediatr Infect Dis J 10:60–564
  Cornelissen JBWJ, Gaasenbeek CPH, Boersma W, Borgsteede FHM, Van Milligen FJ (1999) Use of a pre-selected epitope of cathepsin-L1 in a highly specific peptide-based immunoassay for the diagnosis of Fasciola hepatica infections in cattle. Int J Parasitol 29:685–696CrossRef PubMed
  Cornelissen JBWJ, Gaasenbeek CPH, Borgsteede FHM, Holland WG, Harmsen MM, Boersma WJA (2001) Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica Cathepsin-L-like protease. Int J Parasitol 31:728–737CrossRef PubMed
  Csizmas L (1960) Preparation of formalinized erythrocytes. Proc Soc Exp Biol 103:157–163CrossRef PubMed
  Curtale F, Abdel-Fattah M, El-Shazly M, Shamy MY, El-Sahn F (2000) Anaemia among young male workers in Alexandria, Egypt. East Mediterr Health J 6:1005–1016PubMed
  Curtale F, Hassanein YAW, Savioli L (2005) Control of human fasciolosis by selective chemotherapy. Design, cost, and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta. Trans R Soc Trop Med Hyg 99:599–609CrossRef PubMed
  Dalton JP, Heffernan M (1989) Thiol proteases released in vitro by Fasciola hepatica. Mol Biochem Parasitol 35:161–166CrossRef PubMed
  Dalton JP, Tom TD, Strand M (1985) Fasciola hepatica: comparison of immature and mature immunoreactive glycoproteins. Parasite Immunol 7(643):657
  Damian RT (1965) Molecular mimicry in biological adaptation. Science 147:824CrossRef PubMed
  Damian RT (1997) Parasite immune evasion and exploitation: reflections and projections. Parasitolology 115:169–175CrossRef
  Dell A (1987) FAB-massspectrometryof carbohydrates. Adv Carbohydr Chem Biochem 45:19–72CrossRef PubMed
  Dell A, Reason AJ, Khoo KH, Panico M, McDowell RA, Morris HR (1994) Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol 230:108–132CrossRef PubMed
  Diaz A, Espino AM, Marcet R, Otero O, Torries D, Finlay CM, Sarracent J (1998) Partial characterization of the epitope on excretory-secretory products of Fasciola hepatica recognized by monoclonal antibody Es78. J Parasitol 84:55–61CrossRef PubMed
  Dixit AK, Yadav SC, Sharma RL (2002) The 28 kDa Fasciola gigantica Cysteine proteinase in the diagnosis of prepatent ovine fasciolosis. Vet Parasitol 109:233–247CrossRef PubMed
  Dixit AK, Yadav SC, Sharma RL (2004) Experimental bubaline fasciolosis: kinetics of antibody response using 28 kDa Fasciola gigantica Cysteine proteinase as antigen. Trop Anim Health Prod 36:49–54CrossRef PubMed
  El Ridi R, Salah M, Wagih A, William H, Tallima H, El Shafie MH, Abdel Khalek T, El Amir A, Abo Ammou FF, Motawi H (2007) Fasciola gigantica excretory–secretory products for immunodiagnosis and prevention of sheep fasciolosis. Vet Parasitol 149:219–228CrossRef PubMed
  El-Shazly AM, El-Nahas HA, Abdel-Mageed AA, El Beshbishi SN, Azab MS, Abou El Hasan M, Arafa WA, Morsy TA (2005) Human fascioliasis and anaemia in Dakahlia Governorate, Egypt. J Egypt Soc Parasitol 35:421–432PubMed
  Espinoza JR, Maco V, Marcos L, Saez S, Neyra V, Terashima A, Samalvides F, Gotuzzo E, Chavarry E, Huaman MC, Bargues MD, Adela Valero M, Mas-Coma S (2007) Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 76:977–982PubMed
  Fagbemi BO, Guobadia EE (1995) Immunodiagnosis of fasciolosis in ruminants using a 28-kDa cysteine protease of Fasciola gigantica adult worms. Vet Parasitol 57:309–318
  Fagbemi BO, Obarisiaghon IO, Mbuh JV (1995) Detection of circulating antigen in sera of Fasciola gigantica infected cattle with antibodies reactive with a Fasciola-specific 88 kDa antigen. Vet Parasitol 58:235–246CrossRef PubMed
  Fukuda M, Kobata A (1993) Glycobiology a practical approach. IRL Press, Oxford
  Georgieva K, Georgieva S, Mizinska Y, Stoitsova SR (2012) Fasciola hepatica miracidia: lectin binding and stimulation of in vitro miracidium-to-sporocyst transformation. Acta Parasitol 57:46–52CrossRef PubMed
  Ghosh S, Rawat P, Gupta SC, Singh BP (2005a) Comparative diagnostic potentiality of ELISA and dot-ELISA in preparent diagnosis of experimental Fasciola gigantica infection in cattle. Indian J Exp Biol 43:36–41
  Ghosh S, Rawat P, Velusamy R, Joseph D, Gupta SC, Singh BP (2005b) 27 KDa Fasciola gigantica glycoprotein for the diagnosis of prepatent fasciolasis in cattle. Vet Res Commun 29:123–135CrossRef PubMed
  Gubadia EE, Fagbemi BO (1997) The isolation of Fasciola gigantica- specific antigens and their use in the serodiagnosis of fasciolosis in sheep by the detection of circulating antigens. Vet Parasitol 68:269–282CrossRef
  Hanna REB (1980) Fasciola hepatica : audioradiography of protein synthesis, transport and secretion by the tegument. Exp Parasitol 50:297CrossRef PubMed
  Haridy FM, Morsy TA, Gawish NI, Antonios TN, Abdel Gawad AG (2002) The potential reservoir role of donkeys and horses in zoonotic fascioliasis in Gharbia Governorate, Egypt. J Egypt Soc Parasitol 32:561–570PubMed
  Haridy FM, El-Sherbiny GT, Morsy TA (2006) Some parasitic flukes infecting farm animals in Al-Santa Center, Gharbia Governorate, Egypt. J Egypt Soc Parasitol 36:259–264PubMed
  Haslam SM, Coles GC, Munn EA, Smith TS, Smith HF, Morris HR, Dell A (1996) Haemonchus contortus glycoproteins contain N-linked oligosaccharides with novel highly fucosylated core structures. J Biol Chem 271:30561–30570CrossRef
  Haslam SM, Coles GC, Reason AJ, Morris HR, Dell A (1998) The novel core fucosylation of Haemonchus contortus N-glycans is stage specific. Mol Biochem Parasitol 93:143–147CrossRef PubMed
  Haslam SM, Morris HR, Dell A (2001) Mass spectrometric strategies: providing structural clues for helminth glycoproteins. Trends Parasitol 17:231–235CrossRef PubMed
  Haslam SM, Restrepo BI, Obregon-Henao A, Teale JM, Morris HR, Dell A (2003) Structural characterization of the N-linked glycans from Taenia solium metacestodes. Mol Biochem Parasitol 126:103–107CrossRef PubMed
  Hillyer GV, de Sagramoso Ateca I (1979) Immunity in Schistosoma mansoni using antigens of Fasciola hepatica isolated by Concanavalin—a affinity chromatography. Infect Immune 26:802–807
  Hirabayashi J, Kasai K (2002) Separation technologies for glycomics. J Chromatog 771:67–87
  Hokke CH, Deelder AM, Hoffmann KF, Wuhrer M (2007) Glycomics-driven discoveries in schistosome research. Exp Parasitol 117:275–283CrossRef PubMed
  Hrzenjak T, Castek A, Kliajic K (1984) Characterization of glycolipide complex isolated from Fasciola hepatica. Period Boil 86:327–334
  Hussein AA, Khalifa RMA (2010a) Fascioliasis prevalences among animals and human in Upper Egypt. J King Saud Univ (Sci) 22:15–19CrossRef
  Hussein AA, Khalifa RMA (2010b) Phenotypic description and prevalence of Fasciola species in Qena Governorate, Egypt with special reference to a new strain of Fasciola hepatica. J King Saud Univ (Sci) 22:1–8CrossRef
  Jezek J, El Ridi R, Salah M, Wagih A, Aziz HW, Tallima H, El Shafie MH, Abdel Khalek T, Abo Ammou FF, Strongylis C, Moussis V, Tsikaris V (2007) Fasciola gigantica Cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis. Biopolymers (Pept Sci) 88:20–28CrossRef
  Khoo KH, Dell A (2001) Glycoconjugates from parasitic helminths: structure diversity and immunol biological. Adv Exp Med Biol 491:185–205CrossRef PubMed
  Kumar N, Ghosh S, Gupta SC (2008) Early detection of Fasciola gigantica infection in buffaloes by enzyme-linked immunosorbent assay and dot enzyme-linked immunosorbent assay. Parasitol Res 103:141–150CrossRef PubMed
  Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685CrossRef PubMed
  Lee CJ, Lee LH, Koizumi K (2002a) Polysaccharide vaccines for prevention of encapsulated bacterial infections: Part 1. Infect Med 19:127–133
  Lee CJ, Lee LH, Koizumi K (2002b) Polysaccharide vaccines for prevention of encapsulated bacterial infections: Part 2. Infec Med 19:179–182
  Leverly SB, Weiss JB, Salyan MK, Roberts CE, Hakomori S, Hangnani JL, Strand M (1992) Characterization of a series of novel fucose-contaning glycosphinogolipid immunogens from eggs of Schistosoma mansoni. J Biol Chem 267:5542–5551
  Lowry OH, Rosenbrough NJ, Farr AL, Randael RJ (1951) Protein measurement with the folin phenol reagent. J Biologic Chemist 193:265–275
  Mazyad SA, El- Nemr HI (2004) The endoparasites of sheep and goats and shepherd in North Sinai Governerate, Egypt. J Egypt Soc Parasitol 32:119–126
  McAllister HC, Nisbet AJ, Skuce PJ, Knox DP (2011) Using lectins to identify hidden antigens in Fasciola hepatica. J Helminthol 6:1–7
  Mezo M, González-Warleta M, Ubeira FM (2007) The use of MM3 monoclonal antibodies for the early immunodiagnosis of ovine fascioliasis. J Parasitol 93:65–72CrossRef PubMed
  Molloy JB, Anderson GR, Fletcher TI, Landmann J, Knight BC (2005) Evaluation of a commercially available enzyme-linked immunosorbent assay for detecting antibodies to Fasciola hepatica and Fasciola gigantica in cattle, sheep and buffaloes in Australia. Vet Parasitol 130:207–212CrossRef PubMed
  Morsy TA, Salem HS, Haridy FM, Rifaat MM, Abo-Zenadah NY, Adel el-Kadi M (2005) Farm animals’ Fasciolosis in Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate. J Egypt Soc Parasitol 35:825–832PubMed
  Muro A, Ramajo V, Lopez J, Simon F, Hillyer GV (1997) Fasciola hepatica vaccination of rabbits with native and recombinant antigens related to fatty acid binding proteins. Vet Parasitol 69:219–229CrossRef PubMed
  Newton SEE, Meeusen TN (2003) Progress and new technologies for developing vaccine against gastrointestinal nematode parasites of sheep. Parasite Immunol 25:283–296CrossRef PubMed
  Nyame AK, Kawar ZS, Cummings RD (2004) Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Biochem Biophys 426:182–200CrossRef
  O’Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007–4021PubMed PubMedCentral
  Oldham G (1983) Antibodies to Fasciola hepatica antigens during experimental infections in cattle measured by ELISA. Vet Parasitol 13:151–158CrossRef PubMed
  Periago MV, Valero MA, El Sayed M, Ashrafi K, El Wakeel A, Mohamed MY, Desquesnes M, Curtale F, Mas-Coma S (2008) First phenotypic description of Fasciola hepatica/Fasciola gigantica intermediate forms from the human endemic area of the Nile Delta, Egypt Infection. Genet Evol 8:51–58CrossRef
  Raina OK, Yadav SC, Sriveny D, Gupta SC (2006) Immunodiagnosis of bubaline fasciolosis with Fasciola gigantica cathepsin-L and recombinant cathepsin L 1-D protease. Acta Trop 98:145–151CrossRef PubMed
  Sampaio-Silva ML, Da Costa JM, Da Costa AM, Pires MA, Lopes SA, Castro AM, Monjour L (1996) Antigenic components of excretory-secretory products of adult Fasciola hepatica recognized in human infections. Am J Trop Med Hyg 54:146–148PubMed
  Sanchez-Andrade R, Paz-Silva A, Suarez J, Panadero R, Diez-Banos P, Morrondo P (2000) Use of sandwich enzyme-linked immunosorbent assay (SEA) for the diagnosis of natural Fasciola hepatica infection in cattle from Galicia (NW Spain). Vet Parasitol 93:39–46CrossRef PubMed
  Santiago N, Hillyer GV (1988) Antibody profile by EITB and ELISA of cattle and sheep infected with Fasciola hepatica. J Parasitol 74:810–818CrossRef PubMed
  Snedecor GW, Cochran WC (1982) Statical methods, 7th edn. Iowa State University Press, Ames
  Spithill TW, Dalton JP (1998) Progress in development of liver fluke vaccines. Parasitol Today 14:224–228CrossRef PubMed
  SPSS 11 (2002) Statical package for social science, SPSS for windows Release.111.0.0, 12 June, 2002. Standard Version, copyright SPSSInc., 1989–2002
  Sriveny D, Raina OK, Yadav SC, Chandra D, Jayraw AK, Singh M, Velusamy R, Singh BP (2006) Cathepsin L cysteine proteinase in the diagnosis of bovine Fasciola gigantica infection. Vet Parasitol 135:25–31CrossRef PubMed
  Timanova A, HJokdananova R, Radoslavova G, Deevska I, Barrett J (2003) Fatty acid binding protein from Fasciola hepatica: purification and binding characteristics. Exp Pathol Parasitol 6:213–217
  Towbin H, Stachelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci USA 176:4350–4354CrossRef
  Van Die I, Cummings RD (2010) Glycan gimmickry by parasitic helminths: a strategy for modulating the host immune response? Glycobiology 20:2–12CrossRef PubMed
  Wisnewski N, McNeil M, Grieve RB, Wassom DL (1993) Characterisation of novel fucosyl- and tyvelosyl-containing glycoconjugates from Trichinella spiralis muscle stage larvae. Mol Biochem Parasitol 61:25–35CrossRef PubMed
  Wuhrer M, Berkefeld C, Dennis RD, Idris MA, Geyer R (2001) The liver flukes Fasciola gigantica and Fasciola hepatica express the leucocyte cluster of differentiation marker CD77 (globotriaosylceramide) in their tegument. Biol Chem 382:195–207CrossRef PubMed
  Wuhrer M, Grimm C, Zähringer U, Dennis RD, Berkefeld CM, Idris MA, Geyer R (2003) A novel GlcNAc1-HPO3–6Gal (1-1) ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver-fluke Fasciola hepatica. Glycobiology 13:129–137CrossRef PubMed
  Wuhrer M, Grimm C, Dennis RD, Idris MA, Geyer R (2004) The parasitic trematode Fasciola hepatica exhibits mammalian-type glycolipids as well as Gal (ß1-6) Gal-terminating glycolipids that account for cestode serological cross-reactivity. Glycobiology 14:115–126CrossRef PubMed
  Wuhrer M, Koeleman CA, Deelder AM, Hokke CH (2006a) a) Repeats of LacdiNAc and fucosylated LacdiNAc on N-glycans of the human parasite Schistosoma mansoni. FEBS J 273:347–361CrossRef PubMed
  Wuhrer M, Koeleman CA, Hokke CH, Deelder AM (2006b) Mass spectrometry of proton adducts of fucosylated N-glycans: fucose transfer between antennae gives rise to misleading fragments. Rapid Commun Mass Spectr 20:1747–1754CrossRef
  Yadav SC, Saini M, Raina OK, Nambi PA, Jadav K, Sriveny D (2005) Fasciola gigantica cathepsin-l cysteine proteinase in the detection of early experimental fasciolosis in ruminants. Parasitol Res 97:527–534CrossRef PubMed
  Yamasaki H, Aoki T, Oya H (1989) A cysteine proteinase from the liver fluke Fasciola spp.: purification, characterization, localization and application to immunodiagnosis. Jpn J Parasitol 38:373–384
  Young AR, Barcham GJ, McWilliam HE, Piedrafita DM, Meeusen EN (2012) Galectin secretion and binding to adult Fasciola hepatica during chronic liver fluke infection of sheep. Vet Immunol Immunopathol 145:362–367CrossRef PubMed
  
• 作者单位：Eman H. Abdel-Rahman (2)
  Azza H. Mohamed (1)
  Adel A. H. Abdel-Rahman (3)
  Eman E. El Shanawany (2)
  
  2. Department of Parasitology and Animal Diseases, National Research Center, Giza, Egypt
  1. Department of Zoology, Faculty of Science, Menoufia University, Shebin- El Kom, Egypt
  3. Department of Chemistry, Faculty of Science, Menoufia University, Shebin- El Kom, Egypt
  
• 刊物主题：Infectious Diseases; Health Promotion and Disease Prevention; Medicine/Public Health, general;
• 出版者：Springer India
• ISSN：0975-0703

文摘

In the present study, the carbohydrate structures associated with Fasciola gigantica adult worm were identified by indirect hemagglutination inhibition test. Glucose was found to be the main monosaccharide associated with the fluke. According to indirect hemagglutination inhibition results, purification of glycoprotein fractions from worm crude extract was carried out by affinity chromatography immobilized glucose agarose gel and Con-A lectin columns. The isolated glycoprotein fractions, FI and FII, were characterized by SDS-PAGE which revealed one band in FI of 26 kDa and another one band of 19.5 kDa in FII compared with 12 bands associated with whole worm extract. Both fractions were also characterized by isoelectric focusing technique which proved that both bands were acidic in nature with pIs 6.4 and 6.5 respectively. The comparative diagnostic evaluation of the two isolated glycoprotein fractions and crude extract of experimental fasciolosis in rabbits by ELISA revealed that FII was more potent in the diagnosis during prepatent (first week post infection) and patent periods (10 weeks post infection) than FI and crude extract. Moreover, infected rabbit sera at ten weeks post infection identified both bands; 26 and 19.5 kDa in western blot analysis confirming its immunodiagnostic activities which was proved previously by ELISA. FII proved potency in diagnosis of fasciolosis in 200 buffalo serum samples of different ages and sexes using ELISA which recorded 95 % positive and 5 % negative samples. Moreover, the detailed structural analyses of the most potent fraction, F11, using mass spectrum was made and elucidated chemical structure; O-glycan [Ser-(Arg-Ser-Arg-Ser-GlucNAc)₁₉-GlucNAc]. The present result introduces GlucNAc rich fraction of F .gigantica that can be used successfully in the diagnosis of acute and chronic fasciolosis.